Evidence map›Paper›PMID 39363032›Full record

ArticleScientific reports2024

Characteristics of autosomal dominant WFS1-associated optic neuropathy and its comparability to OPA1-associated autosomal dominant optic atrophy.

Cansu de Muijnck, Lonneke Haer-Wigman, Judith A M van Everdingen, Tanya Lushchyk, Pam A T Heutinck, Marieke F van Dooren, Anneke J A Kievit, Virginie J M Verhoeven, Marleen E H Simon, Rosemarie A Wasmann and 8 more

Abstract readComparative Study
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Cansu de MuijnckDepartment of Ophthalmology, University Medical Center Utrecht, Utrecht, The Netherlands.
Lonneke Haer-WigmanDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Judith A M van EverdingenDepartment of Neuro-Ophthalmology, The Rotterdam Eye Hospital, Rotterdam, The Netherlands.
Tanya LushchykDepartment of Neuro-Ophthalmology, The Rotterdam Eye Hospital, Rotterdam, The Netherlands.
Pam A T HeutinckDepartment of Ophthalmology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Marieke F van DoorenDepartment of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Anneke J A KievitDepartment of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Virginie J M VerhoevenDepartment of Ophthalmology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Marleen E H SimonDepartment of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
Rosemarie A WasmannDepartment of Ophthalmology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Irene C NottingDepartment of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands.
Elfride De BaereCenter for Medical Genetics, Ghent University Hospital, Ghent University, Ghent, Belgium.
Sophie WalraedtDepartment of Ophthalmology, Ghent University Hospital, Ghent, Belgium.
Julie De ZaeytijdDepartment of Ophthalmology, Ghent University Hospital, Ghent, Belgium.
Filip Van den BroeckDepartment of Ophthalmology, Ghent University Hospital, Ghent, Belgium.
Bart P LeroyCenter for Medical Genetics, Ghent University Hospital, Ghent University, Ghent, Belgium.
Camiel J F BoonDepartment of Ophthalmology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
Maria M van GenderenDepartment of Ophthalmology, University Medical Center Utrecht, Utrecht, The Netherlands. mvgenderen@bartimeus.nl.

Funding

Bartiméus Fonds 1219277
6 · The paper itself

Abstract

This study aims to describe the ophthalmic characteristics of autosomal dominant (AD) WFS1-associated optic atrophy (AD WFS1-OA), and to explore phenotypic differences with dominant optic atrophy (DOA) caused by mutations in the OPA1-gene. WFS1-associated diseases, or 'wolframinopathies', exhibit a spectrum of ocular and systemic phenotypes, of which the autosomal recessive Wolfram syndrome has been the most extensively studied. AD mutations in WFS1 also cause various phenotypical changes including OA. The most common phenotype in AD WFS1-associated disease, the combination of OA and hearing loss (HL), clinically resembles the 'plus' phenotype of DOA. We performed a comprehensive medical record review across tertiary referral centers in the Netherlands and Belgium resulting in 22 patients with heterozygous WFS1 variants. Eighteen (82%) had HL in addition to OA. Diabetes mellitus was found in 7 (32%). Four patients had isolated OA. One patient had an unusual phenotype with anterior chamber abnormalities and malformations of the extremities. Compared to DOA, AD WFS1-OA patients had different color vision abnormalities (red-green vs blue-yellow in DOA), abnormal OPL lamination on macular OCT (absent in DOA), more generalized thinning of the retinal nerve fiber layer, and more reduced and delayed pattern reversal visual evoked potentials.

Indexed as

GTP PhosphohydrolasesMembrane ProteinsMutationOptic Atrophy, Autosomal DominantPhenotypeAdolescentAdultAgedChildFemaleHumansMaleMiddle AgedWolfram SyndromeYoung AdultGTP PhosphohydrolasesMembrane ProteinsOPA1 protein, humanwolframin proteinDOAInherited optic neuropathyOPA1Optic atrophyWFS1

Identifiers

PMID39363032
PMCPMC11450207

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.